Saturday

2nd Mar 2024

Advice on AstraZeneca varies across EU, amid blood clot fears

  • Despite the calls for coordination, member states began recommending different age limits for the AstraZeneca vaccine (Photo: Cheshire East Council)

The European Commission has said national experts should work together with the European Medicines Agency (EMA) to develop a "coherent approach" across the EU for the AstraZeneca vaccine.

The call comes as a jumble of measures emerged from EU governments, in response to concerns over rare blood clots.

Read and decide

Join EUobserver today

Get the EU news that really matters

Instant access to all articles — and 20 years of archives. 14-day free trial.

... or subscribe as a group

"Vaccination is a national competence, and member states may decide to follow a stricter approach when it comes to vaccines. [But] vaccination decisions in one member state can affect, of course, those in other member states," a commission spokesperson said on Thursday (8 April).

EU health ministers held an extraordinary virtual meeting on Wednesday, hours after the EU drug regulator found a possible link between AstraZeneca's coronavirus vaccine and rare cases of unusual blood clots with low blood platelets.

However, they failed to adopt a common guidance for its use given the "different interpretations" of the conclusions of the EMA's report.

EU commissioner for health Stella Kyriakides called, on Wednesday, for a coordinated European approach to ensure that "on the basis of the same set of evidence, similar decisions are taken in different member states".

"It is essential that we follow a coordinated European approach ... which does not confuse citizens, and that does not fuel vaccine hesitancy," she told ministers at the meeting, Reuters reported.

Despite the calls for coordination, member states began recommending different age limits for the use of the AstraZeneca vaccine.

"This is a technical decision ... not a political decision," warned Portuguese health minister Marta Temido, whose country currently holds the EU Council presidency.

Different age limits

The Netherlands, Germany, Italy, and Spain have all limited the use of the AstraZeneca vaccine to people aged over 60.

France and Belgium said the jab should only be given to those aged 55 and over.

And in Finland and Sweden, only people aged 65 and over will receive the jab.

Other countries in the bloc have not set age limits.

But British authorities have recommended that adults aged under 30 should be offered an alternative vaccine to the AstraZeneca jab.

Meanwhile, Germany has also recommended that those under 60 who have had a first AstraZeneca shot should receive a different vaccine for their second dose.

But the EU regulator said on Wednesday that there are no guidelines on the "mixing and matching" of different Covid-19 vaccines since there is no related data submitted or assessed so far by the EMA.

This new strategy is at odds with the initial approach in some member states, such as Germany, and France, which initially recommended AstraZeneca only for people under 65, or Italy and Spain, which recommended it only to those under 55, arguing that trial data for the elderly was insufficient.

Earlier in March, a dozen EU countries paused the vaccination with AstraZeneca over emerging reports of blood clotting - even though no causal link had been proven.

Lower trust?

Data from a survey published on Thursday revealed that citizens' trust in AstraZeneca is now lower than for other vaccines.

Among those who are not vaccinated, 65 percent showed some concern about the British-Swedish vaccine compared with about one-third for the other vaccines.

The EU agency pointed out on Wednesday that the benefits of the AstraZeneca jab still outweigh its risks, adding that it will continue monitoring the safety and effectiveness of this jab and other vaccines authorised in the EU.

The EMA's analysis is based on 164 cases of the rare brain blood clot, among 34 million doses administrated across the bloc.

By comparison, four women out of 10,000 would probably get a blood clot from taking the birth control pill.

Opinion

A neuroscientist writes on AstraZeneca fears

Irrespective of whether or not the decision to pause the AstraZeneca vaccine was political, it is clear that governments around the world are not solely basing their vaccination rollout on scientific evidence.

Opinion

Brexit, tabloid 'sulks', and AstraZeneca

A closer look at the events, however, shows that instead of a conspiracy the decision was old-fashioned bureaucratic caution. Isolated quotes by European officials were used to suit ideological agendas.

EU drugs agency plays down AstraZeneca 'blood clot' fears

The European Medicines Agency has said that the benefits of AstraZeneca's vaccine continue to outweigh the risks - suggesting countries can continue using the British-Swedish jab. Several member states have suspended its use over blood-clot concerns.

EU mulls legal action against AstraZeneca over shortfalls

The European Commission said on Thursday it has not yet decided whether to take legal action against AstraZeneca for failing to meet its contractual obligations - but repeated that all options are still on the table.

EU takes AstraZeneca to court for 'breaching contract'

The European Union has launched legal action against the pharmaceutical multinational AstraZeneca for failing to meet its contractual obligations for the supply of Covid-19 vaccines, and for lacking a "reliable strategy" to ensure timely deliveries.

Opinion

Why are the banking lobby afraid of a digital euro?

Europeans deserve a digital euro that transcends the narrow interests of the banking lobby and embodies the promise of a fairer and more competitive monetary and financial landscape.

Opinion

For Ukraine's sake, pass the EU due diligence directive

The EU Commission's 2022 CSDDD proposal did not include provisions incorporating "conflict due diligence", they were added, after the Russian invasion, by the European Parliament and Council into the final directive text — for Ukraine's sake, vote for it.

Latest News

  1. EU docks €32m in funding to UN Gaza agency pending audit
  2. 'Outdated' rules bar MEP from entering plenary with child
  3. Commission plays down row over Rwanda minerals pact
  4. EU socialists set to anoint placeholder candidate
  5. Why are the banking lobby afraid of a digital euro?
  6. Deepfake dystopia — Russia's disinformation in Spain and Italy
  7. Putin's nuclear riposte to Macron fails to impress EU diplomats
  8. EU won't yet commit funding UN agency in Gaza amid hunger

Stakeholders' Highlights

  1. Nordic Council of MinistersJoin the Nordic Food Systems Takeover at COP28
  2. Nordic Council of MinistersHow women and men are affected differently by climate policy
  3. Nordic Council of MinistersArtist Jessie Kleemann at Nordic pavilion during UN climate summit COP28
  4. Nordic Council of MinistersCOP28: Gathering Nordic and global experts to put food and health on the agenda
  5. Friedrich Naumann FoundationPoems of Liberty – Call for Submission “Human Rights in Inhume War”: 250€ honorary fee for selected poems
  6. World BankWorld Bank report: How to create a future where the rewards of technology benefit all levels of society?

Stakeholders' Highlights

  1. Georgia Ministry of Foreign AffairsThis autumn Europalia arts festival is all about GEORGIA!
  2. UNOPSFostering health system resilience in fragile and conflict-affected countries
  3. European Citizen's InitiativeThe European Commission launches the ‘ImagineEU’ competition for secondary school students in the EU.
  4. Nordic Council of MinistersThe Nordic Region is stepping up its efforts to reduce food waste
  5. UNOPSUNOPS begins works under EU-funded project to repair schools in Ukraine
  6. Georgia Ministry of Foreign AffairsGeorgia effectively prevents sanctions evasion against Russia – confirm EU, UK, USA

Join EUobserver

EU news that matters

Join us